Searching…
IR-780 iodide is a near-infrared lipophilic cation heptamethine fluorescent dye. It has a good fluorescent intensity and can be used as a photothermal therapy agent.
IR780 is a prototypic NIR heptamethine cyanine agent, with a high molar extinction coefficient. The maximum excitation wavelength of IR780 was 777-780 nm, and the maximum emission wavelength was 798-823 nm. IR780 can ...
IR780 iodide | C36H44ClIN2 | CID 118987185 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists...
IR780 is a heptamethine cyanine fluorescent probe for in vivo imaging of tumor cells. 1 It displays excitation/emission maxima of 780/799 nm, respectively. 2 IR780 is transported into tumor cells, an effect that can b...
The self-assembled transferrin-IR780 nanoparticles (Tf-IR780 NPs) exhibited narrow size distribution, good photo-stability and encouraging photothermal performance with enhanced generation of ROS ...
IR780, a molecule with a strong optical absorption and emission in the near infrared (NIR) region, is receiving an increasing attention from researchers working in the area of cancer treatment and imaging. Upon irradi...
IR-780 is a near‐infrared fluorescent dye, is used for the exclusive characterization of human CSCs through the HIF‐1α/glycolysis dependent mitochondrial transporter ABCB10's activity.
The PEGylation of drug-carrying nanoparticles has often been used to prolong blood circulation and improve drug deposition at tumor sites. Nevertheless, the PEG-rich hydrophilic surfaces retard the release of the payl...
Nonetheless, IR-780, a heptamethine dye, was found to be a more powerful and stable nanotheranostic agent than ICG, exhibiting several distinct advantages [12, 13]. The hydrophobic nature of IR-780 enables its encapsu...
IR780, a small molecule with a strong optical property and excellent photoconversion efficiency following near infrared (NIR) irradiation, has attracted increasing attention in the field of cancer treatment and imagin...
